Dr. Sebastian Scheich of University Hospital Frankfurt will receive around €2 million over the next six years through the ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...

Law enforcement officials are still desperately searching for leads in the investigation into the disappearance of ...

Why dead bacteria are the secret to a happier gut - Postbiotics are stealing the spotlight for their ability to support ...

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

By Priyanjana Pramanik, MSc. A controlled crossover trial finds that short-term consumption of unprocessed beef is on par ...

A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing complex symptoms and treatment challenges. Discover her journey and management strategies. Dr. Shune discusses how ...

If you're trying to increase your potassium intake but can't stand bananas, eat these foods rich in the essential mineral and ...

HONG KONG SAR - Media OutReach Newswire - 3 February 2026 - Liver cancer is one of the three deadliest cancers worldwide, and ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...